Participant-Reported Symptoms and Their Effect on Long-Term Adherence in the International Breast Cancer Intervention Study I (IBIS I) (vol 35, pg 2666, 2017)

被引：0
|
作者：
Smith
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 03期
关键词：
D O I：
10.1200/JCO.2017.77.1956
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：304 / 304
页数：1
相关论文
共 50 条
  • [1] Participant-Reported Symptoms and Their Effect on Long-Term Adherence in the International Breast Cancer Intervention Study I (IBIS I)
    Smith, Samuel George
    Sestak, Ivana
    Howell, Anthony
    Forbes, John
    Cuzick, Jack
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (23) : 2666 - +
  • [2] Participant-reported symptoms as predictors of long-term adherence of endocrine therapy in the International breast cancer intervention studies 2 (IBIS-2)
    Sestak, Ivana
    Smith, Samuel
    Sleeth, Michelle
    Howell, Anthony
    Cuzick, Jack
    CANCER RESEARCH, 2018, 78 (04)
  • [3] Early participant-reported symptoms as predictors of adherence to anastrozole in the International Breast Cancer Intervention Studies II
    Sestak, I.
    Smith, S. G.
    Howell, A.
    Forbes, J. F.
    Cuzick, J.
    ANNALS OF ONCOLOGY, 2018, 29 (02) : 504 - 509
  • [4] Menopausal symptoms as predictors of long-term adherence in the International breast cancer intervention study (IBIS-1)
    Smith, S. G.
    Sestak, I.
    Forbes, J.
    Howell, A.
    Cuzick, J. J.
    CANCER RESEARCH, 2017, 77
  • [5] Change in marnmographic density after cessation of tamoxifen: results from international breast cancer intervention study I (IBIS I).
    Gao, J. N.
    Forbes, J. F.
    Warren, R. M. L.
    Cuzick, J.
    Howell, A.
    D'Este, C.
    Warren-Forward, H.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S56 - S56
  • [6] First results from the International Breast Cancer Intervention study (IBIS-I): A randomized prevention trial
    Budach, W
    STRAHLENTHERAPIE UND ONKOLOGIE, 2003, 179 (09) : 650 - 651
  • [7] 16 year long-term follow-up of the IBIS-I breast cancer prevention trial
    Cuzick, Jack
    Sestak, Ivana
    Cawthorn, Simon
    Hamed, Hisham
    Holli, Kaija
    Howell, Anthony
    Forbes, John F.
    CANCER RESEARCH, 2015, 75
  • [8] Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial
    Cuzick, Jack
    Sestak, Ivana
    Cawthorn, Simon
    Hamed, Hisham
    Holli, Kaija
    Howell, Anthony
    Forbes, John F.
    LANCET ONCOLOGY, 2015, 16 (01): : 67 - 75
  • [9] Efficacy and adverse effects of breast conserving therapy in stage I and II breast cancer - a long-term study
    Strobl, B
    Janni, W
    Rjosk, D
    Bergauer, F
    Kriegel, S
    Rack, B
    Sommer, H
    Dimpfl, T
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2002, 62 (02) : 155 - 162
  • [10] Long-term results of tamoxifen prophylaxis for breast cancer-96-month follow-up of the randomized IBIS-I trial
    Cuzick, Jack
    Forbes, John F.
    Sestak, Ivana
    Cawthorn, Simon
    Hamed, Hisham
    Holli, Kaija
    Howell, Anthony
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (04): : 272 - 282
12345